Vimentin is a novel anti-cancer therapeutic target; insights from In Vitro and In Vivo mice xenograft studies

Keyphrases

• Vimentin 100%
• Anticancer Therapeutics 100%
• Cancer Therapeutic Target 100%
• Xenograft Studies 100%
• Mouse Xenograft 100%
• In Vivo Mouse 100%
• Withaferin A 50%
• Soft Tissue Sarcoma 33%
• Apoptosis 16%
• Caspase 16%
• Epithelial-to-mesenchymal Transition 16%
• Overexpression 8%
• Knockdown 8%
• Tumor Growth 8%
• Endothelial Cells 8%
• Tumor Cells 8%
• Therapeutic Approaches 8%
• Induced Response 8%
• Clinical Setting 8%
• Pro-apoptotic 8%
• Drug-induced 8%
• Angiogenesis 8%
• Epithelial Cancer 8%
• Signal Process 8%
• Structural Integrity 8%
• Cell Signaling 8%
• Growth in Vitro 8%
• Local Recurrence 8%
• Caspase Inhibitor 8%
• Mesenchymal Cells 8%
• Activated Cells 8%
• Intermediate Filaments 8%
• Antiangiogenic Activity 8%
• Quiescent Cells 8%
• Adhesion Cell 8%
• Survival Signaling 8%
• Bioactive Compounds 8%
• Survival Migration 8%
• Adhesion Signaling 8%
• Naturally-derived 8%
• Local Metastasis 8%
• Dynamic Assembly 8%
• Minimal Effects 8%
• Migration Cells 8%
• Adhesion/migration 8%
• Xenograft Experiment 8%
• Assembly/disassembly 8%

Veterinary Science and Veterinary Medicine

• Mouse 100%
• Cancer 100%
• Vimentin 100%
• In Vitro 100%
• Soft-Tissue Sarcoma 33%
• Neoplasm 16%
• Bioactive Compound 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Vimentin 100%
• Withaferin A 50%
• Soft Tissue Sarcoma 33%
• Caspase 16%
• Recurrent Disease 8%
• Tumor Growth 8%
• Neoplasm 8%
• Caspase Inhibitor 8%
• Antiangiogenic 8%